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There is an increasing interest in systems based on micro/nanotechnologies for 
ultrasensitive and miniaturised biosensors. Oenomics and proteomics sensing are fields 
where label-free and real time measurement of the interactions (as antigenlantibody or 
DNA hybridization) are demanded. A highly multidisciplinary approach including 
microelectronics, MEMS, micro/nanotechnologies, molecular biology, 
nanobiotechnology and chemistry are needed for the implementation of such new 
analytical devices. 
Within this new generation of biosensors, we have fabricated a nanophotonic Mach­
Zehnder device based on evanescent wave detection. For biosensing purposes, a layer of 
receptor molecules (proteins, DNA ...) that are capable ofbinding the analyte molecules 
in a selective way has to be previously immobilised on the biosensor surface. When the 
complementary analytes are flowing over the surface can be direcdy recognised by the 
receptor through a change in the properties of the sensor. In this way, the interacting 
components do not need to be labelled and complex sampIes can be analysed without 
purification. 
In the other hand, a new class of biosensors based on nanomechanÍCs has been 
developed for specific detection of trace amounts of biological molecules in real-time 
without the need of labelling on a portable device. We are developing a microsystem 
able to detect the hybridization of nucleic acids partly complementary to human genes. 
The biosensor microsystem consists of: i) an array of twenty microcantilevers as 
biosensing tranducers, ii) an opticaI detection system (lasers and photodetectors) 
capable of measuring the cantilever movement with sub-nanometer resolution and iii) a 
polymer microfluidic system for reagents delivery to the biosensor. 
Among the variety of optical methods, the utilization of the Surface Plasmon Resonance 
principIes as immunosensing technique has grown steadily in recent years. Applications 
of the SPR phenomenon to biosensing range from clinical, industrial control processes, 
veterinary field or food industry to environmental monitoring. The sensing mechanism 
is based on variations of the refractive index ofthe medium adjacent to the metal sensor 
surface during the interaction of an anaIyte to its corresponding receptor, previously 
immobilized at the sensor surface. The recognition of the complementary molecule by 
the receptor causes a change in the refractive index and the sensor monitors that change. 
After the molecular interaction, the surface can be regenerated using a suitable reagent 
to remove the bound analyte without denaturing the immobilized receptor. 
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